The partners pooled results from two trials and two different dosing regimens, one appearing to be more effective than the other. They hope to produce 3 billion doses in 2021 with an emphasis on serving poorer countries.
Walgreens announced that it is expanding its specialty pharmacy offerings. Experts think that this move could yield several strategic benefits, given the higher profit margins…
If you advise self-insured employers on healthcare benefits, your expert insights will help provide a comprehensive perspective of the state of healthcare benefits for employers…
Embedding patient financing options into the billing process presents a very clear solution for providers and patients to balance affordability and increase collectability.
Regeneron Pharmaceuticals is collaborating with CRISPR technologies startup Mammoth Biosciences to develop in vivo gene-editing therapies. The deal marks the third pharmaceutical industry partnership for…
How health tech startups can successfully adapt the principles to their business ideas
People do not have to die waiting for a kidney. A VBC approach can lead to earlier identification of kidney disease and better management in…
More than 33,000 Providence employees filed a class-action complaint against the health system in 2021, alleging that it had been withholding their wages by denying…
Day One Biopharmaceuticals drug Ojemda is now FDA-approved for advanced pediatric low-grade glioma, the most common type of brain cancer in children. The regulatory decision…
Game-changing advances can be achieved by integrating patient collaboration and priorities into the full span of trial design.
it is paramount that we address both cholesterol risk and inflammation to reduce the risk of a heart attack or stroke.
